US Nuclear Advances Fight Against Opioid Crisis With Breakthrough Fentanyl Detection Technology
LOS ANGELES, CA, Nov. 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – In 2022, fentanyl was responsible for 200 deaths every day, more than 73,000 total, and over a quarter of a million Americans have died from a fentanyl overdose since 2018. In a groundbreaking move to combat the ongoing opioid epidemic, US Nuclear Corp (OTC-QB: UCLE) now offers the world’s first automatic, on-the-spot fentanyl detectors. This cutting-edge technology is designed to enhance the capabilities of law enforcement agencies, first responders, and healthcare professionals in identifying and combating the illicit trafficking of fentanyl. Fentanyl is now endemic in America and USN recommends fighting back by deploying and using these detectors just as widely as metal detectors.
Related news for (UCLE)
- US Nuclear Corp. Announces First Quarter 2024 Results
- US Nuclear’s Unparalleled PFAS Monitoring Products in Spotlight as EPA Sets First-Ever Limits on PFAS
- US Nuclear Delivers First Batch of Tritium Monitoring Systems to Nation’s Largest Public Power Company
- US Nuclear’s Overhoff Delivers the Goods to U.S. DOE
- US Nuclear’s Overhoff Branch is Fusion Energy’s Go-To Tritium Monitoring Solution